Results 81 to 90 of about 8,787,182 (356)
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Blinatumomab is a bispecific T‐cell engager approved for the treatment of pediatric B‐cell acute lymphoblastic leukemia (B‐ALL). Outpatient home infusion reduces hospitalization burden and optimizes resource utilization, but is logistically challenging.
Angela Parra del Riego +10 more
wiley +1 more source
A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors
Journal of Immunotherapy for Cancer, 2018 BackgroundEscalating healthcare costs are necessitating the practice of value-based oncology. It is crucial to critically evaluate the economic impact of influential but expensive therapies such as immune checkpoint inhibitors (ICIs).
V. Verma +6 more
semanticscholar +1 more source
A Bayesian approach to stochastic cost-effectiveness analysis [PDF]
, 2001 The aim of this paper is to discuss the use of Bayesian methods in cost-effectiveness analysis (CEA) and the common ground between Bayesian and traditional frequentist approaches.
Briggs, A.
core
Cost-effectiveness of physical fitness training for stroke survivors [PDF]
, 2018 Background Physical fitness is impaired after stroke, yet fitness training after stroke reduces disability. Several international guidelines recommend that fitness training be incorporated as part of stroke rehabilitation. However, information about cost-
Clifton, E. +3 more
core +3 more sources
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing autoimmune disease of the central nervous system. High‐dose intravenous methylprednisolone (IVMP) is the standard first‐line therapy for acute attacks, although some patients remain refractory.
Wataru Horiguchi +5 more
wiley +1 more source
Measuring efficiency of public hospitals under the impact of Covid-19: the case of Türkiye
Cost Effectiveness and Resource Allocation, 2023 The Covid-19 pandemic has had serious medical, administrative and financial effects on the health system and hospitals around the world. In Türkiye, compared to 2019 realizations, in 2020 and 2021 respectively there were 39% and 21% decrease in the ...
Seher Nur Sülkü +2 more
doaj +1 more source
Cost–effectiveness thresholds: pros and cons
Bulletin of the World Health Organization, 2016 Cost–effectiveness analysis is used to compare the costs and outcomes of alternative policy options. Each resulting cost–effectiveness ratio represents the magnitude of additional health gained per additional unit of resources spent.
M. Bertram +6 more
semanticscholar +1 more source
Cell wall target fragment discovery using a low‐cost, minimal fragment library
FEBS Letters, EarlyView.LoCoFrag100 is a fragment library made up of 100 different compounds. Similarity between the fragments is minimized and 10 different fragments are mixed into a single cocktail, which is soaked to protein crystals. These crystals are analysed by X‐ray crystallography, revealing the binding modes of the bound fragment ligands.
Kaizhou Yan +5 more
wiley +1 more source
Panel discussion on the application of MCDA tools
Cost Effectiveness and Resource Allocation, 2018 Prioritization in healthcare is particularly sensitive to subjective biases and data asymmetry. Yet making data-based and objective decisions are critical to optimizing long term individual and societal benefit.
Michael Watson
doaj +1 more source
Cost Effectiveness and Resource Allocation, 2023 Introduction This study investigates Iranian men’s willingness to pay (WTP) for prostate cancer (PCa) screening and influencing factor, along with the impact of information.
Hiro Farabi +5 more
doaj +1 more source